Bring OLC to market
Not delivered by the deadline
AI-confirmed · human review in progress Independent AI checks agreed on primary SEC or regulator evidence. Records are now being reviewed by hand, starting with those our customers order.
- Announced
- 13 Nov 2024
- Due
- 31 Dec 2025
- Checked
- 1 Oct 2026
- Deadline
- Met
- Late
- Not met
- Today
What the company said
“bringing this innovative new treatment to market in the second half of 2025.”
What we found
Evidence strength A What the grades mean
The company did not bring OLC to market by the end of 2025, as it received a Complete Response Letter (CRL) from the FDA on June 30, 2025, delaying the process.
-
A Unicycive Therapeutics, Inc. 10-Q filed 2026-05-12
“following receipt of a CRL on June 30, 2025.” ✓ confirmed on the page
Market reaction: the shares moved +6.5% against the S&P 500 over the three sessions around the disclosure (11 May 2026 to 14 May 2026). What this measures
Checked 1 Oct 2026.
Commitment DNA
The structured record of this commitment. Fields the company did not state are left blank rather than guessed.
- Event type
- Product other
- Indicative materiality
- Low rules
- Action
- Bring
- Deliverable
- OLC treatment
- In the company’s control
- Medium
- Specificity
- Medium
- Conditional
- Yes: If approved
- Depends on
- Regulatory
How this entry was checked
- Commitment recordedThe company's words were matched word for word against the filing.
- First checkAn AI model, Gemini (Google), read the company's later filings and recorded the outcome with a quoted passage.
- Second check: agreesA different AI model, Claude (Anthropic), re-read the evidence without being told the outcome and reached the same answer.
- Third check on a negative finding: agreesBecause a negative finding could harm a company if wrong, a stronger model re-read the evidence fully blind and reached the same answer.
Confirmed. This outcome counts towards the company's Kept Score. How verification works
Are you Unicycive Therapeutics, Inc.? You can publish an official statement next to this entry, free. Add a statement.
Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.
Report an error in this entry Reference: KI-C-2024-UNCY-002807 · Corrections policy